Skip to content
DataLookout
Menu

SUNRISENCT05752292

Study to Understand Risk Information to Support and Empower

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 11 versions: 9 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 9 words
    • Trial status changed: Enrolling by Invitation → Active, Not Recruiting
  2. Minor Primary completion moved earlier from Dec 2026 to Mar 23, 2026v10
  3. Notable Primary and study completion dates pushed to Dec 2026v9
  4. Minor Secondary endpoints: 2 to 3v8
  5. Notable Primary completion date: Sep 2025 to Apr 2026
    • Study completion date: Feb 2026 to Jul 2026
    v7
Show 3 earlier versionsHide 3 earlier versions
  1. Minor Site details revisedv6
  2. Notable Eligibility criteria expanded, about 5 wordsv3
  3. Minor Start date changed from estimate of Mar 2023 to Apr 13, 2023v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Completion of recommended postpartum diabetes screening.
Timeframe: 4-12 weeks postpartum

Secondary (2)

Completion of any recommended postpartum diabetes screening test.
Uptake of a lifestyle program for diabetes prevention.

Arms and interventions

Condition 1Experimental

Standard health message + VA + TRI + MI+ AP

Condition 2Experimental

Standard health message + VA + TRI + MI

Condition 3Experimental

Standard health message + VA + TRI + AP

Condition 4Experimental

Standard health message + VA + TRI

Condition 5Experimental

Standard health message + VA + MI+ AP

Condition 6Experimental

Standard health message + VA + MI

Condition 7Experimental

Standard health message + VA + AP

Condition 8Experimental

Standard health message + VA

Condition 9Experimental

Standard health message + TRI + MI+ AP

Condition 10Experimental

Standard health message + TRI + MI

Condition 11Experimental

Standard health message + TRI + AP

Condition 12Experimental

Standard health message + TRI

Condition 13Experimental

Standard health message + MI+ AP

Condition 14Experimental

Standard health message + MI

Condition 15Experimental

Standard health message + AP

Condition 16Experimental

Standard health message

Behavioral: Standard Health Information, Values Affirmation (VA), Tailored Risk Information (TRI), Motivational Interviewing-based (MI), Action planning (AP)

Sites

1 site in 1 country

  • Kaiser Permanente Northern CaliforniaPleasanton, California, United States